Comorbidities in Psoriasis Patients

Through a multidisciplinary approach, by taking into account every organ system, we can hope to improve the management of psoriasis and ultimately the long-term quality of life in the psoriasis population.

March 1, 2010|Psoriasis Collection

Psoriasis is a chronic inflammatory disorder that affects approximately 2% of the general population. Numerous studies have evaluated the increased prevalence of comorbid diseases and risk factors in psoriatic patients, including obesity, metabolic syndrome, cardiovascular disease, psoriatic arthritis, autoimmune disease, psychiatric illness, liver disease, smoking, malignancy, chronic obstructive pulmonary disease, sleep apnea, and alcohol abuse. Insight into the overlapping pathogenesis of these comorbidities of psoriasis highlights the importance of immune-mediated mechanisms in these disease states. Psoriasis, with its comorbidities, must be approached in a multidisciplinary manner to effectively and comprehensively understand, manage, and treat those with this complex disorder.

*For a PDF of the full article, click on the link to the left of this introduction.

Download Article